Nanocage-Based Capture-Detection System for the Clinical Diagnosis of Autoimmune Disease, Small, 24 May2021
Small, 24 May, 2021, DOI：https://doi.org/10.1002/smll.202101655
Nanocage-Based Capture-Detection System for the Clinical Diagnosis of Autoimmune Disease
Yanan Zhang, Yingni Li, Jianlin Zhang, Xuehui Chen, Ruofei Zhang, Guoming Sun, Bing Jiang, Kelong Fan, Zhanguo Li, Xiyun Yan
The detection of autoantibodies is critical for diagnosis of autoimmune diseases. However, the sensitivity is often limited by the properties of the antigens and the detection systems such as enzyme-linked immunosorbent assay (ELISA). Here, employing the multidisplay ability of ferritin, a highly sensitive nanocage-based capture-detection system is designed, of which the sensitivity is 100–1000-fold higher than that of conventional ELISA methods. The capture nanocages are constructed by displaying the primary Sj?gren's syndrome (pSS)-related antigenic peptides on ferritin nanocage, which present epitopes effectively and high affinity, leading to tenfold higher capture capability for autoantibodies. Human IgG Fc-binding peptides are also engineered on ferritin nanocage, which enable high binding affinity and efficient horseradish peroxidase (HRP)-labeling. Compared with commercial HRP-conjugated anti-human IgG antibody, the nanocage-based detecting probe exhibited more than tenfold increased sensitivity. Autoantibodies are then examined in 91 sera from patients with pSS, 51 from rheumatoid arthritis, 54 from systemic lupus erythematosus, and 55 from healthy individuals by using the nanocage-based ELISA. The results indicate that the nanocage-based capture-detection system is an effective detection platform and provide a novel and more sensitive method for the diagnosis of autoimmune diseases.